The API Innovation Center (APIIC) has been awarded funding by the Administration for Strategic Preparedness and Response’s (ASPR) Center for Industrial Base Management and Supply Chain (IBMSC) to lead the development and domestic production of three critical active pharmaceutical ingredients (APIs) used in the treatment of asthma, diabetes, and anxiety disorders.   Each API was chosen for its vital role in U.S. health care, shortage history, as well as inclusion on essential medicines lists: ...